SEC Form 4 · accession 0001070081-18-000056
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Gregory Almstead
Officer — EVP Research Pharma Ops & Tech
Period of report
Jun 19, 2018
Accepted (ET)
Jun 21, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 19, 2018 | M | 20,000 | $10.85 | A | 37,154 | D | |
| Common StockF2 | Jun 19, 2018 | S | 8,000 | $48.09 | D | 29,154 | D | |
| Common StockF3 | Jun 19, 2018 | S | 12,000 | $48.46 | D | 17,154 | D | |
| Common Stock | holding | — | — | — | 5,125 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F4 | $10.85 | Jun 19, 2018 | M | 20,000 | D | — | May 15, 2023 | Common Stock | 20,000 | 46,898 | D |
| Stock Option (Right To Buy)F4 | $451.20 | holding | — | — | — | — | May 15, 2019 | Common Stock | 200 | 200 | D |
| Stock Option (Right To Buy)F4 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 200 | 200 | D |
| Stock Option (Right To Buy)F4 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 216 | 216 | D |
| Stock Option (Right To Buy)F4 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 166 | 166 | D |
| Stock Option (Right To Buy)F4 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 3,102 | 3,102 | D |
| Stock Option (Right To Buy)F4 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 40,000 | 40,000 | D |
| Stock Option (Right To Buy)F5 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 69,550 | 69,550 | D |
| Stock Option (Right To Buy)F6 | $30.86 | holding | — | — | — | — | Jan 3, 2026 | Common Stock | 55,000 | 55,000 | D |
| Stock Option (Right To Buy)F7 | $11.23 | holding | — | — | — | — | Jan 2, 2027 | Common Stock | 35,000 | 35,000 | D |
| Stock Option (Right To Buy)F8 | $18.01 | holding | — | — | — | — | Jan 2, 2028 | Common Stock | 70,000 | 70,000 | D |
| Stock Option (Right To Buy)F4 | $508.80 | holding | — | — | — | — | Oct 7, 2019 | Common Stock | 12 | 12 | I |
| Stock Option (Right To Buy)F4 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 1 | 1 | I |
| Stock Option (Right To Buy)F4 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 7 | 7 | I |
| Stock Option (Right To Buy)F4 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 7 | 7 | I |
| Stock Option (Right To Buy)F4 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 1,300 | 1,300 | I |
| Stock Option (Right To Buy)F5 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 2,060 | 2,060 | I |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.58 to $48.37 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.38 to $48.81 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4Currently exercisable.
- F5This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- F6This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- F7This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
- F8This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.